Blood stories

What if off-the-shelf is not enough for your needs?

Study almost anything with custom assay development

The drug development process can be a long and bumpy road with a vast array of parameters to check and validate. Sanquin PBS can help with any challenges that arise through custom assay development and validation.
Read more

Donor blood helps ensure safer medicines

Investigating medication safety using MAT

Blood donations save human lives and can help get medication to patients safely. Sanquin uses immune cells taken from donor blood to investigate the safety of medicines.
Read more

How do biotherapeutics talk to the human body?

Monitoring biotherapeutics for informed decision-making

Biotherapeutics are widely used and present a promising solution to many diseases. Their concentration in blood, their longevity and the effective dose need to be monitored to ensure a safe dose range and to confirm efficacy. Sanquin PBS is a key opinion leader in the field and has developed and provided quality biotherapeutic assays for decades.
Read more

How do we capitalize on the versatile effects of antibodies?

A is for antibody

New technologies have led to the generation of increasingly specific and powerful antibody treatments. Sanquin can help unravel their story using the ABCs of blood.
Read more

Why do clients turn to Sanquin PBS when faced with difficult cells?

Working with “difficult” cells

Just because a cell is difficult to work with doesn’t mean that it should be excluded from quality, safety, or efficacy controls. Through its vast experience and an optimized workflow, Sanquin PBS can study all aspects of difficult-to-handle blood cells including phagocytosis, degranulation, NETosis, migration, cytokine release, and apoptosis.
Read more

What do we miss when we don’t look at the whole picture?

Unlocking the whole story in blood

Whole blood assays can measure direct and indirect drug interactions in a setup that reflects the natural environment in the body, catching any unforeseen effects that usually materialize later in the pipeline. Sanquin PBS is one of the few partners worldwide that can screen compounds on a large scale in whole blood for e.g. cytokine production, or complement activation.
Read more